National Vaccine
Information Center

Your Health. Your Family. Your Choice.
Search Results

From the 1/7/2022 release of VAERS data:

This is VAERS ID 365936

Government Disclaimer on use of this data

Case Details

VAERS ID: 365936 (history)  
Form: Version 1.0  
Age: 15.0  
Sex: Female  
Location: Foreign  
   Days after vaccination:1
Submitted: 2009-11-06
   Days after onset:42
Entered: 2009-11-06
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other       Purchased by: Other
Symptoms: Blood product transfusion, Gait disturbance, Guillain-Barre syndrome, Paraesthesia, Paralysis
SMQs:, Peripheral neuropathy (narrow), Anticholinergic syndrome (broad), Parkinson-like events (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Demyelination (narrow), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Hypoglycaemia (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 0 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions: Cough
Diagnostic Lab Data: UNK
CDC Split Type: B0601391A

Write-up: This case was reported by a regulatory authority (# NL-LRB-92275) and described the occurrence of Guillain-Barre Syndrome in a 15-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). The subject''s medical history included cough. No concomitant medication. On 24 September 2009 the subject received 3rd dose of CERVARIX (intramuscular) lot number unknown. On 25 September 2009, 1 day after vaccination with CERVARIX, the subject experienced paresthesia (in feet and calf). On 28 September 2009 the subject had unspecified paralysis (she fell with her bike and she could not put her foot on the pedal). On 04 October 2009 she had abnormal gait. The general practitioner referred her to the physiotherapist. The subject was referred to the pediatrician and neurologist who diagnosed Guillain-Barre Syndrome. The subject was hospitalized. The subject was treated with normal immunoglobulin (Immunoglobulin). At the time of reporting the outcome of the events were unspecified. The regulatory authority reported that Guillain Barre Syndrome was unlikely to be related to vaccination with CERVARIX. No further information was available as this was all the information that regulatory authorities had.

New Search

Link To This Search Result:

Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166